INTERNATIONAL PATENT: TAKEDA PHARMACEUTICAL COMPANY LIMITED FILES APPLICATION FOR "IDES-RAPAMYCIN CONJUGATE IN AAV GENE THERAPY"

GENEVA, April 19 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1, Doshomachi 4-chomeChuo-kuOsaka-shi, Osaka 541-0045) filed a patent application (PCT/IB2024/059972) for "IDES-RAPAMYCIN CONJUGATE IN AAV GENE THERAPY" on Oct 11, 2024. With publication no. WO/2025/079025, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KHAN, Tayeba (c/o Millennium Pharmaceuticals, Inc.40 Landsdowne StreetCambridge, Massachusetts 02139), KENNISTON, Jon A. (c/o Millennium Pharmaceuticals, Inc.40 Landsdowne StreetCambridge, Massachusetts 02139), ...